Free Trial

Sandoz Group (OTCMKTS:SDZNY) Stock Price Down 0.9% - Here's What Happened

Sandoz Group logo with Medical background

Key Points

  • Sandoz Group's stock price decreased by 0.9%, closing at $56.78 after trading as low as $56.10.
  • The Royal Bank of Canada upgraded Sandoz Group’s rating from "hold" to "moderate buy," indicating a positive shift in analyst sentiment.
  • Sandoz Group specializes in developing and marketing generic pharmaceuticals and biosimilars across multiple therapeutic areas, including oncology and infectious diseases.
  • Want stock alerts on Sandoz Group? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY - Get Free Report)'s share price dropped 0.9% during mid-day trading on Tuesday . The company traded as low as $56.10 and last traded at $56.78. Approximately 20,913 shares changed hands during trading, a decline of 4% from the average daily volume of 21,781 shares. The stock had previously closed at $57.31.

Wall Street Analyst Weigh In

Separately, Royal Bank Of Canada raised shares of Sandoz Group from a "hold" rating to a "moderate buy" rating in a research report on Friday, May 2nd.

Get Our Latest Stock Analysis on Sandoz Group

Sandoz Group Trading Down 5.9%

The company has a current ratio of 1.24, a quick ratio of 0.79 and a debt-to-equity ratio of 0.57. The stock's 50-day simple moving average is $55.31 and its 200-day simple moving average is $48.14.

Sandoz Group Company Profile

(Get Free Report)

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.

Featured Stories

Should You Invest $1,000 in Sandoz Group Right Now?

Before you consider Sandoz Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sandoz Group wasn't on the list.

While Sandoz Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines